Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma
黑色素瘤患者在抗PD-1/L1治疗失败后接受帕博利珠单抗联合伊匹木单抗治疗
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.21.00079
Olson, Daniel J; Eroglu, Zeynep; Brockstein, Bruce; Poklepovic, Andrew S; Bajaj, Madhuri; Babu, Sunil; Hallmeyer, Sigrun; Velasco, Mario; Lutzky, Jose; Higgs, Emily; Bao, Riyue; Carll, Timothy C; Labadie, Brian; Krausz, Thomas; Zha, Yuanyuan; Karrison, Theodore; Sondak, Vernon K; Gajewski, Thomas F; Khushalani, Nikhil I; Luke, Jason J